Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001265772 | SCV001443941 | uncertain significance | Inborn genetic diseases | 2017-12-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001732099 | SCV001982439 | likely pathogenic | not provided | 2021-09-20 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate V178M results in impaired SFTPA2 secretion (Tsui et al., 2018); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26568241, 31796085, 25553246, 30854216, 32855221) |
Alder lab, |
RCV001780219 | SCV002573690 | pathogenic | Interstitial lung disease 2 | 2022-02-01 | criteria provided, single submitter | research | |
Juno Genomics, |
RCV001780219 | SCV005417867 | likely pathogenic | Interstitial lung disease 2 | criteria provided, single submitter | clinical testing | PM2_Supporting+PS3_Supporting+PS4_Moderate+PP1+PP4 | |
OMIM | RCV001780219 | SCV002016364 | pathogenic | Interstitial lung disease 2 | 2021-11-18 | no assertion criteria provided | literature only |